1,2-Dipalmitoyl-rac-glycerol
1,2-Dipalmitoyl-rac-glycerol
製品概要
クイックビュー
- 製品ファミリー
- LNP & Nucleic Acid Delivery Lipids
- 化学名
- 1,2-Dipalmitoyl-rac-glycerol
- 分子式
- C35H68O5
- 分子量
- 568.9
1,2-Dipalmitoyl-rac-glycerol is also indexed as glyceryl 1,2-dipalmitate, 1,2-dipalmitin, and 1,2-dipalmitoylglycerol.
Identifiers include CAS 40290-32-2, molecular formula C35H68O5, molecular weight about 568.9, and PubChem CID 99931.
The related shorthand DG(16:0/16:0/0:0)[rac] may be useful when comparing lipid-name records.
同定情報と仕様
| Catalog No. | CH51065 |
| CAS No. | 40290-32-2 |
| Chemical Name | 1,2-Dipalmitoyl-rac-glycerol |
| Molecular Formula | C35H68O5 |
| Molecular Weight | 568.9 |
| PubChem CID | 99931 |
用途情報
- Diglyceride identity reference: supports matching 1,2-Dipalmitoyl-rac-glycerol with glyceryl 1,2-dipalmitate and CAS 40290-32-2.
- Lipid-name comparison: helps match 1,2-dipalmitin, 1,2-dipalmitoylglycerol, and DG(16:0/16:0/0:0)[rac] names across records.
- Category-fit note: this record is treated here as a 1,2-diglyceride identity rather than a phospholipid identity.
補足材料情報
用途
Useful for aligning 1,2-Dipalmitoyl-rac-glycerol, glyceryl 1,2-dipalmitate, CAS 40290-32-2, and PubChem CID 99931 in catalog or reference-data checks.
特性
- 1,2-diglyceride identity with two palmitoyl chains on a racemic glycerol backbone.
- PubChem CID 99931 matches CAS 40290-32-2, formula C35H68O5, and molecular weight about 568.9.
- Direct application literature for the exact catalog identity was No public CID cited.
関連技術資料
公開情報源
- (+-)-1,2-Dipalmitoylglycerol | PubChem CID 99931
- High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing
PNAS, 2018
Product-family technical context
- Selective organ targeting nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing
Nature Nanotechnology, 2020
Product-family technical context
- Rational Design of Cationic Lipids for siRNA Delivery
Nature Biotechnology, 2010
Product-family technical context
- Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
Molecular Therapy, 2013
Product-family technical context
類似製品
材料選択の支援が必要ですか？
CHEMOSは製品適合性、目標構造、ルート上の課題、分析要件、プロジェクト別供給ニーズを確認します。